CJC-1295 Co / Evidence
Evidence
CJC-1295: mechanism, DAC vs no-DAC, and the evidence
CJC-1295 extends GH pulses via GHRH receptor binding. Here's what the half-life data, DAC vs no-DAC science, and ipamorelin pairing actually show.
CJC-1295 and athlete drug testing: what gets caught
CJC-1295 is banned in sport under WADA's S2 peptide hormones class, detectable via biomarker passport testing, not standard urine panels.
CJC-1295: what animal studies show vs human evidence
CJC-1295's core data is one 2005 human PK/PD trial (Teichman et al.) plus older GHRH animal work. No large human safety trials exist. Here's what's real.
CJC-1295 before and after claims: what's real, what's not
CJC-1295 before/after photos are common online but unsupported by trials. Here's what the actual GH and IGF-1 data show, and how to read the claims.
CJC-1295 clinical trials: what the human data actually shows
CJC-1295 has one published human trial (2006, 80 subjects). Here's what it found, what's still folklore, and how it differs from GHRP-2/ipamorelin studies.
CJC-1295 human studies: what the actual data shows
CJC-1295 human trials are small and short. Here's what the 2006 Teichman study and related GHRH research actually found, and what's still unproven.
CJC-1295 in women: dosing, safety, and what the data shows
No clinical trials test CJC-1295 in women specifically. Here's what the GHRH and GH physiology data actually say about sex differences, dosing, and risks.
CJC-1295 mechanism of action: how it triggers GH release
CJC-1295 binds GHRH receptors on pituitary somatotrophs to pulse GH release. Learn the DAC vs no-DAC difference, half-life data, and ipamorelin pairing logic.
CJC-1295 peptide results: what the evidence actually shows
CJC-1295 raises GH and IGF-1 in trials, but human fat loss or muscle data barely exist. Here's what's proven, what's folklore, and what to expect.
CJC-1295 results: what the research actually shows
CJC-1295 raised GH and IGF-1 by 200-300%+ in a 2006 Mol Cell Endocrinol trial. Here's the real human data, the DAC vs no-DAC split, and what's still unproven.
CJC-1295 stacks: ipamorelin, GHRP-6, and what evidence says
How CJC-1295 is stacked with ipamorelin and other peptides, what the DAC vs non-DAC choice means for dosing, and where the evidence actually ends.
CJC-1295 with DAC: mechanism, half-life, and evidence
CJC-1295 with DAC has a reported 5.8-8.1 day half-life vs about 30 minutes for the no-DAC version. Here's what the human study actually showed.
Good alternatives for CJC-1295 peptide, compared honestly
Tesamorelin is FDA-approved, sermorelin has decades of use, CJC-1295 without DAC mimics natural GHRH pulses. Here's how the real alternatives stack up.
What does CJC-1295 actually do to your body?
CJC-1295 is a GHRH analogue that raises GH and IGF-1 pulses. Here's what the actual pharmacology studies show, versus forum claims, with real numbers.